Prof. Vijay Pancholi from Ohio State University visited Translational Health Science and Technology Institute (THSTI) on 12^th December 2022. During his visit, he delivered a talk on "Targeting Ser/Thr/Tyr (STY) phosphorylation-related post-translational modifications to abate antimicrobial resistance." Prof. Pancholi in collaboration with Dr. Shailendra Asthana, THSTI is working towards developing small molecules for Antimicrobial resistance (AMR).